EDGAR Filing Documents for 0001144204-18-014632

Form 8-K - Current report:

SEC Accession No. 0001144204-18-014632

Filing Date

2018-03-14

Accepted

2018-03-14 15:57:24

Documents

Period of Report

2018-03-08

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tv488514_8k.htm	8-K	35362
2	EXHIBIT 10.1	tv488514_ex10-1.htm	EX-10.1	11367
3	EXHIBIT 10.2	tv488514_ex10-2.htm	EX-10.2	16560
4	EXHIBIT 10.3	tv488514_ex10-3.htm	EX-10.3	29487
	Complete submission text file	0001144204-18-014632.txt		94555

Mailing Address 483 BAY STREET N105 TORONTO A6 M5G2C9

Business Address 483 BAY STREET N105 TORONTO A6 M5G2C9 1.416.640.7887

Bionik Laboratories Corp. (Filer) CIK: 0001508381 (see all company filings)